These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3514798)

  • 1. The biological modification of tumor cells as a means of inducing their regression: an overview.
    Kobayashi H
    J Biol Response Mod; 1986 Feb; 5(1):1-11. PubMed ID: 3514798
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral xenogenization of intact tumor cells.
    Kobayashi H
    Adv Cancer Res; 1979; 30():279-99. PubMed ID: 92180
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor immunology].
    Milas L; Silobrcić V
    Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor regression in tumor-bearing mice by inoculations of immunogenic somatic hybrid cells in combination with cyclophosphamide.
    Tachibana T; Dei T
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):455-63. PubMed ID: 6681341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture.
    Miller JA
    Cancer Res; 1970 Mar; 30(3):559-76. PubMed ID: 4915745
    [No Abstract]   [Full Text] [Related]  

  • 6. [New developments in the area of carcinogenic compounds and their pharmacodynamics (continuation and conclusion)].
    Dannenberg H
    Dtsch Med J; 1967 Jun; 18(12):386-90 concl. PubMed ID: 5608293
    [No Abstract]   [Full Text] [Related]  

  • 7. Viral infections and their mitigation in experimental immunosuppression.
    Mayer V; Mitrová E
    Lek Pr; 1975; 12(1):1-113. PubMed ID: 1218510
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.
    Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H
    Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor immune responses following neoadjuvant immunotherapy with a recombinant adenovirus expressing HSP72 to rodent tumors.
    Krewet JA; Ren W; Huang XF; Chen SY; Shah MR
    Cancer Immunol Immunother; 2005 Oct; 54(10):988-98. PubMed ID: 15889253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic variants induced by mutagens: a mechanism for generating autoimmune responses to tumors.
    Frost P
    Immunol Ser; 1990; 52():53-64. PubMed ID: 2091787
    [No Abstract]   [Full Text] [Related]  

  • 11. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
    Toda M; Iizuka Y; Kawase T; Uyemura K; Kawakami Y
    Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minute virus of mice. II. Prevalence, epidemiology, and occurrence as a contaminant of transplanted tumors.
    Parker JC; Collins MJ; Cross SS; Rowe WP
    J Natl Cancer Inst; 1970 Aug; 45(2):305-10. PubMed ID: 4324609
    [No Abstract]   [Full Text] [Related]  

  • 13. Tum- variants and the detection of tumor-specific transplantation antigens on spontaneous mouse tumors.
    Boon T; van Pel A; Uyttenhove C; Marchand M; Lambotte P
    Behring Inst Mitt; 1984 May; (74):209-13. PubMed ID: 6332616
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemo- and immunotherapy of tumors induced in mice by bcr-abl-transformed cells.
    Sobotkova E; Duskova M; Tachezy R; Petrackova M; Vonka V
    Oncol Rep; 2009 Mar; 21(3):793-9. PubMed ID: 19212641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread occurrence in mammals of antibodies reactive to intracytoplasmic A particles of the mouse mammary tumor virus.
    Zotter S
    Arch Geschwulstforsch; 1983; 53(4):315-9. PubMed ID: 6312921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
    Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
    Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia.
    Ben-Efraim S; Bizzini B; Relyveld EH
    Biomed Pharmacother; 2000 Jun; 54(5):268-73. PubMed ID: 10917465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy of malignant diseases].
    Dorval T; Michon J; Tartour E; Fridman WH
    Bull Cancer; 1995; 82 Suppl 2():127s-138s. PubMed ID: 7542946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency of genomic mutations of tumor cells while cloning in vivo].
    Vakhtin IuB; Borkhsenius TV
    Dokl Akad Nauk SSSR; 1972 Jun; 204(5):1240-2. PubMed ID: 5041958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.